Germany's Altana has initiated discussions to sell its drug business for $7 billion, according to The Wall Street Journal. The report says that Altana is preparing to set up an auction for the drug unit, although it could still back out of the sale. Earlier, Altana officials had outlined a strategy for expanding their pharmaceutical work through acquisitions, alliances and licensing deals.
- read this AFX report for more